Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives

De Boer NKH, Peyrin-Biroulet L, Jharap B, Sanderson JD, Meijer B, Atreya I, Barclay ML, Colombel JF, Lopez A, Beaugerie L, Marinaki AM, Van Bodegraven AA, Neurath M (2018)

Publication Type: Journal article

Publication year: 2018

Journal

Journal of Crohns & Colitis Elsevier

Book Volume: 12

Pages Range: 610-620

Journal Issue: 5

DOI: 10.1093/ecco-jcc/jjx181

Abstract

Thiopurines, available as azathioprine, mercaptopurine, and thioguanine, are immunomodulating agents primarily used to maintain corticosteroid-free remission in patients with inflammatory bowel disease. To provide a state-of-the-art overview of thiopurine treatment in inflammatory bowel disease, this clinical review critically summarises the available literature, as assessed by several experts in the field of thiopurine treatment and research in inflammatory bowel disease.

Authors with CRIS profile

Markus Neurath Lehrstuhl für Innere Medizin I

Involved external institutions

Guy's and St Thomas' (NHS Foundation Trust)

United Kingdom (GB) Université de Lorraine

France (FR) Vrije Universiteit Amsterdam (VU) / University Amsterdam

Netherlands (NL) Christchurch Hospital

New Zealand (NZ) Meander Medisch Centrum

Netherlands (NL) Mount Sinai Hospital (MSH)

Canada (CA) University of Paris 6 - Pierre et Marie Curie / Université Paris VI Pierre et Marie Curie (UPMC)

France (FR)

How to cite

APA:

De Boer, N.K.H., Peyrin-Biroulet, L., Jharap, B., Sanderson, J.D., Meijer, B., Atreya, I.,... Neurath, M. (2018). Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives. Journal of Crohns & Colitis, 12(5), 610-620. https://dx.doi.org/10.1093/ecco-jcc/jjx181

MLA:

De Boer, Nanne K. H., et al. "Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives." Journal of Crohns & Colitis 12.5 (2018): 610-620.

BibTeX: Download